Table 1 Demography and clinical characteristics of the cohort according to the presence of LVO
From: Relationship between leukocyte counts and large vessel occlusion in acute ischemic stroke
|  | LVO present (N = 167) | LVO absent (N = 252) | P value |
|---|---|---|---|
Demographic characteristics | |||
 Age, years, median (IQR) | 68 (61–79) | 69 (59–77) | 0.258 |
 Gender, female, % (n) | 52.1 (87) | 38.5 (97) | 0.006 |
Elapsed times | |||
 Onset-to-sample time, min, median (IQR) | 83 (55–124) | 88 (59–139) | 0.313 |
 Sample-to-CTA time, min, median (IQR) | 16 (6–25) | 12 (5–28) | 0.684 |
Parameters on admission | |||
 NIHSS score on admission, median (IQR) | 12 (7–17) | 6 (4–8) | < 0.001 |
 On admission SBP, mmHg, median (IQR) | 158 (140–177) | 167 (145–180) | 0.004 |
 On admission DBP, mmHg, median (IQR) | 85 (78–96) | 90 (80–100) | 0.004 |
 Body temperature, oC, median (IQR) | 36.4 (36.1–36.5) | 36.4 (36.2–36.6) | 0.069 |
 Blood glucose, mmol/L, median (IQR) | 6.89 (5.90–8.10) | 6.43 (5.61–8.35) | 0.120 |
 INR, ratio, median (IQR) | 1.02 (0.95–1.08) | 0.99 (0.94–1.04) | 0.003 |
Vascular risk factors | |||
 Smoking, % (n), 60 missing | 39.1 (52) | 31.4 (71) | 0.139 |
 Hypertension, % (n), 13 missing | 81.6 (133) | 77.8 (189) | 0.352 |
 Diabetes mellitus, % (n), 19 missing | 21.4 (34) | 30.3 (73) | 0.049 |
 Hyperlipidaemia, % (n), 36 missing | 50.7 (76) | 53.6 (125) | 0.568 |
 Atrial fibrillation, % (n), 23 missing | 32.9 (52) | 17.2 (41) | < 0.001 |
 Coronary artery disease, % (n), 33 missing | 27.7 (43) | 23.4 (54) | 0.332 |
 Chronic heart failure, % (n), 23 missing | 15.0 (24) | 7.6 (18) | 0.019 |
 Previous stroke/TIA, % (n), 22 missing | 17.6 (28) | 25.2 (60) | 0.074 |
 Malignancy, % (n), 31 missing | 16.4 (25) | 9.3 (22) | 0.036 |
Therapy at stroke onset | |||
 Antiplatelet, % (n), 23 missing | 40.3 (62) | 36.0 (87) | 0.388 |
 Anticoagulant, % (n), 28 missing | 17.6 (27) | 9.7 (23) | 0.021 |
 Lipid lowering, % (n), 23 missing | 27.7 (43) | 22.4 (54) | 0.228 |
 Antihypertensive, % (n), 24 missing | 72.9 (113) | 66.7 (160) | 0.190 |
 Antidiabetic, % (n), 24 missing | 16.4 (25) | 24.0 (58) | 0.070 |